Abstract:Tumor necrosis factor-alpha-induced protein 8 (TIPE8) was reported to be involved in promoting the progression of several solid tumors recently. Our goal is to elucidate the expression and roles of TIPE3 in pancreatic cancer. A retrospective cohort with 188 pancreatic cancer patients and a prospective cohort consisting of 66 pancreatic cancer patients were constructed, and the expression of TIPE3 was detected via immunohistochemistry (IHC). The correlations with clinical characteristics including patients’ survival were evaluated. A nomogram including TIPE3 expression was also constructed and validated to predict the prognosis of patients. TIPE3 knock down and overexpression system were constructed using lentivirus mediated transfections, and functional analysis of TIPE3 was investigated in pancreatic cancer cells, as well as pancreatic cancer xenograft mouse model and metastatic mouse model. Both the retrospective and the prospective cohort demonstrated that TIPE3 was highly expressed in pancreatic cancer tissues, and TIPE3 expression was close related with lymph node metastasis and tumor TNM stage. High TIPE3 expression was associated with poor survival of pancreatic cancer patients, and nomogram including TIPE3 expression could predict the prognosis of pancreatic cancer patients effectively. TIPE3 promoted the proliferation, migration and invasion in vitro, and facilitate the progression and metastasis in vivo. Mechanically, TIPE3 promoted RAC1 expression and promoted tumor progression in a RAC1-depedent manner.Funding: The research is supported by: Shandong Provincial Natural Science Foundation, China(No. ZR2020QH225, ZR2012HM046), Key Research Project of Shandong Province,China (2016GGB01022), Qingdao Minsheng Science and Technology Foundation,Shandong, China (No. 14-2-3-5-nsh) and Qingdao Science and Technology PlanProject (No. 13-1-4-220-jch).Declaration of Interest: None to declare. Ethical Approval: All the experimental protocols were approved by the Ethics Committee of Shandong University and the Ethics Committee of Qingdao University, China. Written informedconsent was obtained from all the subjects

TIPE1 impairs sternness maintenance in colorectal cancer through directly targeting -catenin

TIPE1 function as a prognosis predictor and negative regulator of lung cancer

TIPE2 Suppresses Malignancy of Pancreatic Cancer Through Inhibiting TGFβ1 Mediated Signaling Pathway

TIPE1 Suppresses Invasion and Migration Through Down‐regulating Wnt/β‐catenin Pathway in Gastric Cancer

Expression of TIPE family members in human colorectal cancer

TIPE1 Induces Apoptosis by Negatively Regulating Rac1 Activation in Hepatocellular Carcinoma Cells

TIPE Regulates VEGFR2 Expression and Promotes Angiogenesis in Colorectal Cancer.

TIPE2 Suppresses Progression and Tumorigenesis of Esophageal Carcinoma Via Inhibition of the Wnt/β-catenin Pathway

TIPE inhibits ferroptosis in colorectal cancer cells by regulating MGST1/ALOX5

TIPE-mediated Up-Regulation of MMP-9 Promotes Colorectal Cancer Invasion and Metastasis Through MKK-3/p38/NF-κB Pro-Oncogenic Signaling Pathway

TIPE Regulates DcR3 Expression and Function by Activating the PI3K/AKT Signaling Pathway in CRC

Tumor Necrosis Factor (Tnf)-Α-induced Protein 8-Like-2 (TIPE2) Inhibits Proliferation and Tumorigenesis in Breast Cancer Cells.

TIPE1 Suppresses Growth and Metastasis of Ovarian Cancer

Down-regulated expression of TIPE3 inhibits malignant progression of non-small cell lung cancer via Wnt signaling

TNFAIP8 protein functions as a tumor suppressor in inflammation-associated colorectal tumorigenesis

A Novel Prognostic Factor TIPE2 Inhibits Cell Proliferation and Promotes Apoptosis in Pancreatic Ductal Adenocarcinoma (PDAC)

TIPE3 represses head and neck squamous cell carcinoma progression via triggering PGAM5 mediated mitochondria dysfunction

TIPE2 Inhibits GC Via Regulation of Cell Proliferation, Apoptosis and Inflammation

The anti-inflammatory TIPE2 is an inhibitor of the oncogenic Ras.

TIPE3 is a Candidate Prognostic Biomarker Promoting Tumor Progression Via Elevating RAC1 in Pancreatic Cancer.

TIPE2 suppresses angiogenesis and non-small cell lung cancer (NSCLC) invasiveness via inhibiting Rac1 activation and VEGF expression.